Peter Morfeld

Peter Morfeld

Auto-generated profile, based on publicly available information

Peter Morfeld

University of Cologne Institute and Policlinic for Occupational Medicine, Environmental Medicine and Prevention Research, Faculty of Medicine and University Hospital of Cologne Köln, Germany

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2019 in Risk Analysis
Verified
Journal Article
Open access
PDF file
JHJames K. Hammitt
James K. Hammitt
PMPeter Morfeld
Peter Morfeld
JTJouni T. Tuomisto
Jouni T. Tuomisto
TEThomas C Erren
Thomas C Erren
Mortality effects of exposure to air pollution and other environmental hazards are often described by the estimated number of “premature” or “attributable” deaths and the economic value of a reduction in exposure as the product of an estimate of “statistical lives saved” and a “value per statistical life.” These terms can be misleading because the number of deaths advanced by exposure cannot be determined from mortality data alone, whether from epidemiology or randomized trials (it is not statistically identified). The fraction of deaths “attributed” to exposure is conventionally derived as the hazard fraction (R – 1)/R, where R is the relative risk of mortality between high and low exposure levels. The fraction of deaths advanced by exposure (the “etiologic” fraction) can be substantially larger or smaller: it can be as large as one and as small as 1/e (≈0.37) times the hazard fraction (if the association is causal and zero otherwise). Recent literature reveals misunderstanding about these concepts. Total life years lost in a population due to exposure can be estimated but cannot be disaggregated by age or cause of death. Economic valuation of a change in exposure‐related mortality risk to a population is not affected by inability to know the fraction of deaths that are etiologic. When individuals facing larger or smaller changes in mortality risk cannot be identified, the mean change in population hazard is sufficient for valuation; otherwise, the economic value can depend on the distribution of risk reductions.

1 December 2006 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
PMPeter Morfeld
Peter Morfeld
SBSebastian F Büchte
Sebastian F Büchte
JWJürgen Wellmann
Jürgen Wellmann
RMRobert J McCunney
Robert J McCunney
CPClaus Piekarski
Claus Piekarski
We undertook a lung cancer mortality analysis of 1528 German carbon black workers, followed between the years of 1976–1998, who produced furnace black, lamp black, and gas black. We used Cox modeling across age with time-dependent covariates, ie, cumulative and mean carbon black exposure, duration of work in departments, adjusting for calendar time, a smoking indicator, and age at hire. Exposures were lagged up to 20 years. Analyses were performed with the full cohort and after restriction to an inception cohort. A total of 50 lung cancer deaths occurred. No positive association was found with carbon black exposure indices. Some models indicated an increasing risk across duration of work in the lamp black producing department. Our results do not suggest that carbon black exposure is a human lung carcinogen. The lamp black results, if no artifact, may point at historical exposures to gaseous polycyclic aromatic hydrocarbons.

1 December 2006 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
PMPeter Morfeld
Peter Morfeld
SBSebastian F Büchte
Sebastian F Büchte
RMRobert J McCunney
Robert J McCunney
CPClaus Piekarski
Claus Piekarski
IAInternational Carbon Black Association
International Carbon Black Association
We undertook a sensitivity analysis of the lung cancer standardized mortality ratios (SMRs) in a study of 1522 German carbon black workers from 1976 to 1998. We applied results from a case-control study to adjust the SMR for smoking habits and exposures experienced before the carbon black job. In addition, sensitivity to reference rates was explored. On the basis of 47 lung cancer deaths, the SMRs were 1.62, 1.72, and 2.08 (local, state, and national rates, respectively). Adjustment for previous exposures and smoking yielded additional correction factors of 0.64 or 0.74, varying with the chosen reference. Lung cancer SMRs (95% confidence intervals) for the full cohort ranged from 1.20 (0.88-1.59) to 2.08 (1.53-2.77) in this sensitivity analysis. Thus, overall SMRs are only weak measures of causal associations and should be complemented by internal modeling of exposure effects whenever possible.

16 December 2004 in Epidemiologic Perspectives & Innovations
Verified
Journal Article
Open access
PMP Morfeld
P Morfeld
Excess Years of Life Lost due to exposure is an important measure of health impact complementary to rate or risk statistics. I show that the total excess Years of Life Lost due to exposure can be estimated unbiasedly by calculating the corresponding excess Years of Potential Life Lost given conditions that describe study validity (like exchangeability of exposed and unexposed) and assuming that exposure is never preventive. I further demonstrate that the excess Years of Life Lost conditional on age at death cannot be estimated unbiasedly by a calculation of conditional excess Years of Potential Life Lost without adopting speculative causal models that cannot be tested empirically. Furthermore, I point out by example that the excess Years of Life Lost for a specific cause of death, like lung cancer, cannot be identified from epidemiologic data without assuming non-testable assumptions about the causal mechanism as to how exposure produces death. Hence, excess Years of Life Lost estimated from life tables or regression models, as presented by some authors for lung cancer or after stratification for age, are potentially biased. These points were already made by Robins and Greenland 1991 reasoning on an abstract level. In addition, I demonstrate by adequate life table examples designed to critically discuss the Years of Potential Life Lost analysis published by Park et al. 2002 that the potential biases involved may be fairly extreme. Although statistics conveying information about the advancement of disease onset are helpful in exposure impact analysis and especially worthwhile in exposure impact communication, I believe that attention should be drawn to the difficulties involved and that epidemiologists should always be aware of these conceptual limits of the Years of Potential Life Lost method when applying it as a regular tool in cohort analysis.

9 July 2007 in American Journal of Industrial Medicine
Verified
Journal Article
Closed access
PDF file
PMPeter Morfeld
Peter Morfeld
RMRobert J. McCunney
Robert J. McCunney

7 May 2021 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
PMPeter Morfeld
Peter Morfeld
BTBarbara Timmermann
Barbara Timmermann
JGJ. Valérie Groß
J. Valérie Groß
PLPhilip Lewis
Philip Lewis
PCPierluigi Cocco
Pierluigi Cocco
TEThomas C. Erren
Thomas C. Erren
Total mortality and “burden of disease” in Germany and Italy and their states and regions were explored during the first COVID-19 wave by using publicly available data for 16 German states and 20 Italian regions from January 2016 to June 2020. Based on expectations from 2016 to 2019, simplified Standardized Mortality Ratios (SMRs) for deaths occurring in the first half of 2020 and the effect of changed excess mortality in terms of “burden of disease” were assessed. Moreover, whether two German states and 19 Italian cities appropriately represent the countries within the European monitoring of excess mortality for public health action (EuroMOMO) network was explored. Significantly elevated SMRs were observed (Germany: week 14–18, Italy: week 11–18) with SMR peaks in week 15 in Germany (1.15, 95%-CI: 1.09–1.21) and in week 13 in Italy (1.79, 95%-CI: 1.75–1.83). Overall, SMRs were 1.00 (95%-CI: 0.97–1.04) in Germany and 1.06 (95%-CI: 1.03–1.10) in Italy. Significant SMR heterogeneity was found within both countries. Age and sex were strong modifiers. Loss of life expectancy was 0.34 days (1.66 days in men) for Germany and 5.3 days (6.3 days in men) for Italy [with upper limits of 3 and 6 weeks among elderly populations (≥65 years) after maximum potential bias adjustments]. Restricted data used within EuroMOMO neither represents mortality in the countries as a whole nor in their states and regions adequately. Mortality analyses with high spatial and temporal resolution are needed to monitor the COVID-19 pandemic's course.